Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- AdBit's

AdBit's Newsletter

Hyderabad Metro announces TUTEM app to enhance safety of passengers, especially women 25 Apr 2025 06:51 GMT
… safety. Story continues below this ad BITS Pilani Vice-Chancellor Prof V …
FDA Ad Com votes in favor of TransMedics' OCS Liver System 15 Jul 2021 06:44 GMT
Biogen rallies 31% ahead of Ad Com meeting on Alzheimer's med aducanumab 04 Nov 2020 17:49 GMT
FDA Ad Com thumbs down on Neovasc Reducer; shares plummet 36% 28 Oct 2020 12:39 GMT
FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines 21 Oct 2020 19:06 GMT
FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements 06 Oct 2020 16:36 GMT
The FDA's Vaccines and Related Biological Products Advisory Committee will meet on Thursday, October 22, to discuss pre- and post-licensure clinical trials needed to further evaluate the immunogenicity and duration of effectiveness of COVID-19 vaccines …
FDA postpones Ad Com meeting on TransMedics donor heart management system 28 Sep 2020 22:02 GMT
TransMedics (NASDAQ:TMDX) has announced that the FDA has temporarily postponed the Advisory Committee (AdCom) meeting to review its premarket approval application for its OCS Heart, which was originally scheduled for October 7, to have more time to review …
FDA Ad Com thumbs down on mortality benefit claim for Glaxo's Trelegy Ellipta 31 Aug 2020 21:24 GMT
The FDA's Pulmonary-Allergy Drugs Advisory Committee voted 14-1 that the results from the IMPACT study evaluating GlaxoSmithKline's (GSK +0.2%) Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder oral inhalation) in …
Alkermes under modest pressure ahead of Ad Com review of schizo drug 21 Aug 2020 15:34 GMT
Alkermes plc (ALKS -1.9%) is down in early trade, albeit on very light volume, on the heels of the news that an FDA advisory committee will meet on October 9 to review and discuss its marketing application for schizophrenia and bipolar disorder med ALKS …
FDA Ad Com October 9 for Alkermes drug for schizophrenia and bipolar disorder 21 Aug 2020 13:18 GMT
The FDA's Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will meet virtually on Friday, October 9, to review and discuss Alkermes plc's (NASDAQ:ALKS) marketing application seeking approval of …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS